3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
A Standard patent application filed on 21 November 2005 credited to Charrier, Jean-Damien
;
Knegtel, Ronald
;
Mortimore, Michael
;
Studley, John R.
Details
Application number :
2005309776
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
Inventor :
Charrier, Jean-Damien
;
Knegtel, Ronald
;
Mortimore, Michael
;
Studley, John R.
Agent name :
Cullens Patent and Trade Mark Attorneys
Address for service :
Level 32 239 George Street Brisbane QLD 4000 Australia
Filing date :
21 November 2005
Associated companies :
Applicant name :
Vertex Pharmaceuticals Incorporated
Applicant address :
130 Waverly Street Cambridge MA 02139 United States of America